Drugs.com FDA MedWatch AlertsOriginal article
Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
RegulatoryArgatroban InjectionNegative
AI Analysis
Summary
Par Health issued a voluntary nationwide recall of 22 lots of Argatroban Injection 250 mg/2.5 mL due to the presence of particulate matter. The recall was initiated on October 13, 2026, and extends to the hospital/user level.
Outcome Details
Voluntary nationwide recall of 22 lots due to presence of particulate matter
Importance:4/10
Sentiment:
-0.80
product recallquality issueparticulate matterargatroban
Related Companies
Read the original article
Published by Drugs.com FDA MedWatch Alerts on October 13, 2026 1:46 PM